Filer Snapshot

CANNABINOID BIOSCIENCES, INC.

CIK 0001760319. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

41

Latest filing

24 May 2022

Industry

Pharmaceutical Preparations

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for NIHK. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open owner activity Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Forms 3/4/5

4 filed on 24 May 2022 for CIK 0001760319.

View source filing
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Pharmaceutical Preparations (Office of Life Sciences)
Business address
3699 Wilshire Blvd., Suite 610, Los Angeles, CA, 90010
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
CA
Fiscal year end
31 December

Filer intelligence

What SEC filings say about CANNABINOID BIOSCIENCES, INC.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • Forms 3/4/5 show insider context for NIHK.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

NIHK

24 May 2022 · President and CEO · 10% owner

Issuer page Owner page

Latest update

What changed recently for CANNABINOID BIOSCIENCES, INC.

Ownership report updated

Latest ownership report period: 24 May 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

24 May 2022

Page type

Ownership filings

Latest period

24 May 2022

Ownership context was refreshed from SEC Forms 3/4/5 filed on 24 May 2022.

Open ownership filings Browse recent public updates

Benchmark Context

Benchmark context for this company

CANNABINOID BIOSCIENCES, INC. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest ownership report period: 24 May 2022. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

SEC filing record

CIK 0001760319 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
41
First seen
11 Dec 2018
Latest filing
24 May 2022
Entity
Company

Observed form types

4 1-K 1-K/A 1-SA QUALIF CORRESP 1-A POS UPLOAD 1-U SC 13D +4 more

CIK-linked evidence first

CANNABINOID BIOSCIENCES, INC. SEC filings CANNABINOID BIOSCIENCES, INC. owner filings Open SEC filing index

Industry context: Pharmaceutical Preparations.

Latest Filings

Showing the latest 12 of 41 SEC filings for CANNABINOID BIOSCIENCES, INC..

Open full filing history
4 File 000-30786

PRIMARY DOCUMENT

Filing date
24 May 2022
Reporting date
24 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
1-K File 24R-00217

1-K filing

Filing date
28 Apr 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
1-K/A File 24R-00217

1-K/A filing

Filing date
16 Dec 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
1-SA File 24R-00217

1-SA filing

Filing date
19 Oct 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
QUALIF File 024-10924

QUALIF filing

Filing date
09 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A POS File 024-10924

1-A POS filing

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A POS File 024-10924

1-A POS filing

Filing date
20 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A POS File 024-10924

1-A POS filing

Filing date
01 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-K File 24R-00217

1-K filing

Filing date
30 Apr 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .